Report: Pharma execs warm to med reminder apps

It's no secret that poor adherence to medication instructions costs healthcare systems billions of dollars a year, and pharma companies have kicked the tires on technologies to alert patients that it's time to take their meds. In a KPMG study, the global firm cited evidence that one in three pharma executives has taken interest in using mobile tech to provide medication reminders to patients, The Pharma Letter reported. The costs of poor adherence have been felt broadly, and there has always been a question of which party should pay for tech to give patients reminders: insurers, drugmakers, patients themselves? Also, some patients aren't forgetting to take their meds, they just aren't taking them for various reasons. It's a tricky issue that poses challenges to tech providers. Item

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.